We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Generation Bio Co
2 own
3 watching
Current Price
$4.18
$0.15
(3.72%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
248.73M
52-Week High
8.715
52-Week Low
3.4
Average Volume
0.08M
Dividend Yield
--
P/E Ratio
--
Market Capitalization248.73M52-Week High8.71552-Week Low3.4Average Volume0.08MDividend Yield--P/E Ratio--What does the Generation Bio Co do?
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Generation Bio Co make?
News & Events about Generation Bio Co.
Benzinga
1month ago
Latest Ratings for GBIO
DateFirmActionFromTo Dec 2021JMP SecuritiesMaintainsMarket Outperform Dec 2021NeedhamMaintainsBuy Jun 2021JMP SecuritiesInitiates Coverage OnMarket Outperform
View More Analyst Ratings for GBIO
View the Latest Analyst Ratings
read more...
Globe Newswire
3 months ago
CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in the Gene ...
Ticker Report
4 months ago
Generation Bio (NASDAQ:GBIO Get Rating) had its target price reduced by JMP Securities from $11.00 to $7.00 in a report issued on Thursday morning, The Fly reports. JMP Securities currently has a market outperform rating on the stock. Other equities research analysts have also recently ...
Zolmax
7 months ago
Generation Bio Co. (NASDAQ:GBIO Get Rating) COO Antoinette Paone sold 2,828 shares of the firms stock in a transaction on Thursday, September 29th. The shares were sold at an average price of $5.24, for a total value of $14,818.72. The sale was disclosed in a document filed with the SEC, which is ...
Zolmax
8 months ago
Generation Bio Co. (NASDAQ:GBIO Get Rating) Director Charles A. Rowland, Jr. purchased 18,784 shares of the stock in a transaction that occurred on Tuesday, September 13th. The shares were purchased at an average price of $5.20 per share, for a total transaction of $97,676.80. Following the ...
Frequently Asked Questions
Frequently Asked Questions
What is Generation Bio Co share price today?
Can Indians buy Generation Bio Co shares?
How can I buy Generation Bio Co shares from India?
Can Fractional shares of Generation Bio Co be purchased?
What are the documents required to start investing in Generation Bio Co stocks?
What is today’s traded volume of Generation Bio Co?
What is today’s market capitalisation of Generation Bio Co?
What is the 52-Week High and Low Range of Generation Bio Co?
What percentage is Generation Bio Co down from its 52-Week High?
What percentage is Generation Bio Co up from its 52-Week Low?
Current Price
$4.18
$0.15
(3.72%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.